One of Acadia Pharma’s drugs failed to meet goals of a late-stage trial about a schizophrenia treatment.
Source link
Acadia Pharma’s stock falls 15% after failed drug trial
One of Acadia Pharma’s drugs failed to meet goals of a late-stage trial about a schizophrenia treatment.
Source link
